Xtant Medical Holdings, Inc. (XTNT) Financials
XTNT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 92.6 million | 41.3 million |
2023-12-31 | 92.6 million | 41.3 million |
2023-09-30 | 92.0 million | 37.3 million |
2023-06-30 | 65.2 million | 34.3 million |
XTNT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -1.3 million | 938000 |
2023-12-31 | -1.3 million | 938000 |
2023-09-30 | -4.1 million | 745000 |
2023-06-30 | -2.9 million | 439000 |
XTNT Net Income
No data available :(
XTNT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 5.9 million | - | - |
2023-12-31 | - | - | 1.8 million |
2023-09-30 | 8.7 million | - | 1.8 million |
2023-06-30 | 4.1 million | 16.4 million | 1.4 million |
XTNT Shares Outstanding
XTNT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 363000 | 492000 | 8.9 million | 11.6 million |
2023-12-31 | 363000 | 492000 | 20.5 million | - |
2023-09-30 | 223000 | 490000 | 7.1 million | 11.1 million |
2023-06-30 | 414000 | 180000 | 5.0 million | 8.7 million |
XTNT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 28.1 million | 11.0 million |
2023-12-31 | 28.1 million | 11.0 million |
2023-09-30 | 25.0 million | 9.7 million |
2023-06-30 | 20.2 million | 7.8 million |
XTNT
Price: $0.82
52 week price:
Earnings Per Share: 0.01 USD
P/E Ratio: 52.75
Exchange: ASE
Sector: Healthcare
Industry: Medical Devices
Volume: 44500
Market Capitalization: 110.7 million